vs
Apyx Medical Corp（APYX）与Penumbra Inc（PEN）财务数据对比。点击上方公司名可切换其他公司
Penumbra Inc的季度营收约是Apyx Medical Corp的20.1倍（$385.4M vs $19.2M）。Penumbra Inc净利率更高（12.3% vs -6.8%，领先19.1%）。Apyx Medical Corp同比增速更快（34.7% vs 22.1%）。Penumbra Inc自由现金流更多（$68.0M vs $-2.8M）。过去两年Apyx Medical Corp的营收复合增速更高（36.8% vs 17.6%）
Apyx Medical前身是博维医疗，是美国的医疗器械制造商，专注生产电外科产品与能源技术相关医疗设备，公司总部位于佛罗里达州克利尔沃特，在保加利亚设有生产工厂。
Penumbra Inc是2004年由Arani Bose与Adam Elsesser联合创立的美国医疗器械企业，总部位于加利福尼亚州阿拉米达，核心业务为研发、生产中风、动脉瘤等血管疾病介入治疗所用的专业医疗设备，产品已在全球多个国家的临床诊疗场景中投入使用。
APYX vs PEN — 直观对比
营收规模更大
PEN
是对方的20.1倍
$19.2M
营收增速更快
APYX
高出12.6%
22.1%
净利率更高
PEN
高出19.1%
-6.8%
自由现金流更多
PEN
多$70.9M
$-2.8M
两年增速更快
APYX
近两年复合增速
17.6%
损益表 — Q4 2025 vs Q4 2025
| 指标 | | |
|---|---|---|
| 营收 | $19.2M | $385.4M |
| 净利润 | $-1.3M | $47.3M |
| 毛利率 | 62.6% | 68.0% |
| 营业利润率 | 0.1% | 15.4% |
| 净利率 | -6.8% | 12.3% |
| 营收同比 | 34.7% | 22.1% |
| 净利润同比 | 71.9% | 40.6% |
| 每股收益（稀释后） | — | $1.20 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收APYXPEN
| Q4 25 | $19.2M | $385.4M | ||
| Q3 25 | $12.9M | $354.7M | ||
| Q2 25 | $11.4M | $339.5M | ||
| Q1 25 | $9.4M | $324.1M | ||
| Q4 24 | $14.2M | $315.5M | ||
| Q3 24 | $11.5M | $301.0M | ||
| Q2 24 | $12.1M | $299.4M | ||
| Q1 24 | $10.2M | $278.7M |
净利润APYXPEN
| Q4 25 | $-1.3M | $47.3M | ||
| Q3 25 | $-2.0M | $45.9M | ||
| Q2 25 | $-3.8M | $45.3M | ||
| Q1 25 | $-4.2M | $39.2M | ||
| Q4 24 | $-4.6M | $33.7M | ||
| Q3 24 | $-4.7M | $29.5M | ||
| Q2 24 | $-6.6M | $-60.2M | ||
| Q1 24 | $-7.6M | $11.0M |
毛利率APYXPEN
| Q4 25 | 62.6% | 68.0% | ||
| Q3 25 | 64.4% | 67.8% | ||
| Q2 25 | 62.3% | 66.0% | ||
| Q1 25 | 60.1% | 66.6% | ||
| Q4 24 | 63.0% | 66.8% | ||
| Q3 24 | 60.5% | 66.5% | ||
| Q2 24 | 61.7% | 54.4% | ||
| Q1 24 | 58.1% | 65.0% |
营业利润率APYXPEN
| Q4 25 | 0.1% | 15.4% | ||
| Q3 25 | -6.5% | 13.8% | ||
| Q2 25 | -22.6% | 12.0% | ||
| Q1 25 | -32.4% | 12.4% | ||
| Q4 24 | -21.4% | 13.6% | ||
| Q3 24 | -31.6% | 11.7% | ||
| Q2 24 | -45.7% | -27.0% | ||
| Q1 24 | -64.6% | 4.3% |
净利率APYXPEN
| Q4 25 | -6.8% | 12.3% | ||
| Q3 25 | -15.4% | 12.9% | ||
| Q2 25 | -33.2% | 13.3% | ||
| Q1 25 | -44.0% | 12.1% | ||
| Q4 24 | -32.5% | 10.7% | ||
| Q3 24 | -40.9% | 9.8% | ||
| Q2 24 | -54.0% | -20.1% | ||
| Q1 24 | -74.0% | 3.9% |
每股收益（稀释后）APYXPEN
| Q4 25 | — | $1.20 | ||
| Q3 25 | — | $1.17 | ||
| Q2 25 | — | $1.15 | ||
| Q1 25 | — | $1.00 | ||
| Q4 24 | — | $0.88 | ||
| Q3 24 | — | $0.75 | ||
| Q2 24 | $-0.19 | $-1.55 | ||
| Q1 24 | $-0.22 | $0.28 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $31.7M | $186.9M |
| 总债务越低越好 | $37.5M | — |
| 股东权益账面价值 | $14.5M | $1.4B |
| 总资产 | $66.8M | $1.8B |
| 负债/权益比越低杠杆越低 | 2.58× | — |
8季度趋势，按日历期对齐
现金及短期投资APYXPEN
| Q4 25 | $31.7M | $186.9M | ||
| Q3 25 | $25.1M | $321.0M | ||
| Q2 25 | $29.3M | $421.8M | ||
| Q1 25 | $31.0M | $376.1M | ||
| Q4 24 | $31.7M | $324.4M | ||
| Q3 24 | $28.0M | $280.5M | ||
| Q2 24 | $32.7M | $288.3M | ||
| Q1 24 | $37.3M | $223.1M |
总债务APYXPEN
| Q4 25 | $37.5M | — | ||
| Q3 25 | $37.5M | — | ||
| Q2 25 | $37.5M | — | ||
| Q1 25 | $37.5M | — | ||
| Q4 24 | $37.5M | — | ||
| Q3 24 | $37.5M | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益APYXPEN
| Q4 25 | $14.5M | $1.4B | ||
| Q3 25 | $5.8M | $1.4B | ||
| Q2 25 | $7.3M | $1.3B | ||
| Q1 25 | $10.5M | $1.2B | ||
| Q4 24 | $14.2M | $1.2B | ||
| Q3 24 | $11.0M | $1.1B | ||
| Q2 24 | $14.7M | $1.2B | ||
| Q1 24 | $20.3M | $1.2B |
总资产APYXPEN
| Q4 25 | $66.8M | $1.8B | ||
| Q3 25 | $57.4M | $1.7B | ||
| Q2 25 | $58.2M | $1.7B | ||
| Q1 25 | $60.2M | $1.6B | ||
| Q4 24 | $64.8M | $1.5B | ||
| Q3 24 | $60.7M | $1.5B | ||
| Q2 24 | $65.4M | $1.5B | ||
| Q1 24 | $70.7M | $1.6B |
负债/权益比APYXPEN
| Q4 25 | 2.58× | — | ||
| Q3 25 | 6.41× | — | ||
| Q2 25 | 5.17× | — | ||
| Q1 25 | 3.57× | — | ||
| Q4 24 | 2.64× | — | ||
| Q3 24 | 3.40× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-2.5M | $86.5M |
| 自由现金流经营现金流 - 资本支出 | $-2.8M | $68.0M |
| 自由现金流率自由现金流/营收 | -14.6% | 17.7% |
| 资本支出强度资本支出/营收 | 1.4% | 4.8% |
| 现金转化率经营现金流/净利润 | — | 1.83× |
| 过去12个月自由现金流最近4个季度 | $-9.1M | $174.9M |
8季度趋势，按日历期对齐
经营现金流APYXPEN
| Q4 25 | $-2.5M | $86.5M | ||
| Q3 25 | $-3.5M | $58.3M | ||
| Q2 25 | $-1.2M | $44.9M | ||
| Q1 25 | $-702.0K | $49.0M | ||
| Q4 24 | $-2.9M | $51.1M | ||
| Q3 24 | $-4.4M | $56.5M | ||
| Q2 24 | $-4.3M | $22.6M | ||
| Q1 24 | $-6.3M | $38.3M |
自由现金流APYXPEN
| Q4 25 | $-2.8M | $68.0M | ||
| Q3 25 | $-4.1M | $42.0M | ||
| Q2 25 | $-1.5M | $29.4M | ||
| Q1 25 | $-757.0K | $35.5M | ||
| Q4 24 | $-3.2M | $45.7M | ||
| Q3 24 | $-4.6M | $51.0M | ||
| Q2 24 | $-4.6M | $18.1M | ||
| Q1 24 | $-6.4M | $32.5M |
自由现金流率APYXPEN
| Q4 25 | -14.6% | 17.7% | ||
| Q3 25 | -31.5% | 11.8% | ||
| Q2 25 | -13.2% | 8.7% | ||
| Q1 25 | -8.0% | 11.0% | ||
| Q4 24 | -22.4% | 14.5% | ||
| Q3 24 | -40.0% | 16.9% | ||
| Q2 24 | -38.0% | 6.0% | ||
| Q1 24 | -62.2% | 11.7% |
资本支出强度APYXPEN
| Q4 25 | 1.4% | 4.8% | ||
| Q3 25 | 4.0% | 4.6% | ||
| Q2 25 | 2.3% | 4.6% | ||
| Q1 25 | 0.6% | 4.2% | ||
| Q4 24 | 1.7% | 1.7% | ||
| Q3 24 | 1.3% | 1.8% | ||
| Q2 24 | 2.4% | 1.5% | ||
| Q1 24 | 0.3% | 2.1% |
现金转化率APYXPEN
| Q4 25 | — | 1.83× | ||
| Q3 25 | — | 1.27× | ||
| Q2 25 | — | 0.99× | ||
| Q1 25 | — | 1.25× | ||
| Q4 24 | — | 1.52× | ||
| Q3 24 | — | 1.91× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 3.48× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
